WENDEL BRUCE purchased 5.08K shares of GT BIOPHARMA, INC. on the open market
Open‑market purchase worth $26.3K. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 10/7/2021ACC: 0001654954-21-010887
+402.65K
Net shares
Net buyer
$26.3K
Total acquired
3
Open market trades
3B · 0S
5
Total transactions
402.65K acquired
Non-Derivative Transactions4
Common Stock
Direct
Shares
+3.27K
Price / share
$3.14
Trade value
$10.26K
% of position
New position
11/16/2020
0.00→3.27K
Common Stock
Direct
Shares
+1.37K
Price / share
$8.87
Trade value
$12.19K
% of position
42.0%
12/22/2020
3.27K→4.64K
Common Stock
Direct
Shares
+441.00
Price / share
$8.73
Trade value
$3.85K
% of position
9.5%
12/22/2020
4.64K→5.08K
Common Stock
Direct
Shares
+347.57K
Price / share
—
Trade value
—
% of position
6837.9%
2/16/2021
5.08K→352.65K
Total
Net shares
+352.65K
Net value
$26.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/16/2020 | P · Purchase | +3.27K | $3.14 | $10.26K | New position | 0.00 | 3.27K |
| Common Stock Direct | 12/22/2020 | P · Purchase | +1.37K | $8.87 | $12.19K | 42.0% | 3.27K | 4.64K |
| Common Stock Direct | 12/22/2020 | P · Purchase | +441.00 | $8.73 | $3.85K | 9.5% | 4.64K | 5.08K |
| Common Stock Direct | 2/16/2021 | A · Award | +347.57K | — | — | 6837.9% | 5.08K | 352.65K |
| Total | +352.65K | $26.30K | ||||||
Derivative Transactions1
Option to purchase Common Stock
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
6.33
Held after
50K
Exercisable
—
2/16/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock Direct | Common Stock50K shares | 2/16/2021 | A · Award | +50K | 6.33 | — | 50K |